Original Source(s)
Related Content
ACP Suggests First-Line Obesity Drugs
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026
-
5 min
When Should Breast Cancer Risk Scores Trigger MRI?
A JAMA Internal Medicine Viewpoint urges clinicians and health systems to verify risk-model inputs before acting on automated breast cancer screening recommendations.
by Kerri Miller
June 23, 2026
-
3 min
Head-to-Head Trial in Relapsing MS
The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.
July 7, 2026
-
6 min
